SIR-Approximately 40% of Americans will reach 80 years of age, with an average life expectancy of about 8 years thereafter. There will be 31.6 million Americans ≥80 years by 2050, accompanied by a parallel increase in the number of octogenarians with coronary artery and valvular diseases [1] . Aortic stenosis (AS) has become the most common valve disease in adults in Europe and the United States. Currently, aortic valve replacement (AVR) in the ≥80 years age group is performed with acceptable operative mortality [2, 3] .
Older people take longer to recover from surgery; if a signiWcant portion of their life is made miserable by postoperative complications, surgery might be considered unacceptable. As such, the quality of life (QOL) of patients ≥80 years should be evaluated and compared with that of younger counterparts to determine functional outcomes.
Patients and methods

Protocol
Between 1995 and 1999, 58 patients ≥80 years underwent AVR at our institute. All patients were invited to respond preoperatively to the Medical Outcome Study Short Form-36 (SF36) questionnaire and 21 (35%) agreed to do so. The SF-36 measures eight dimensions of QOL: physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH). All patients were mailed an SF-36 questionnaire 6 months postoperatively and this was followed by a request for telephone interview. There were 20 (35%) respondents.
Preoperative scores were compared with those of 20 similar patients <80 years who underwent AVR during the same period and to those of a norm-based (≥75 years) group of non-institutionalised general US population of the same age. Postoperative scores were compared with those of 17 of 20 <80 years patients who underwent AVR during the same period; these groups did not differ in postoperative NYHA class. In addition, they were also compared the general population (≥75 years).
Follow-up
Follow-up was 86% (45/53) complete; eight patients were not reachable. Mean follow-up time was 35.3 ± 25.3 months (median 37.3, range 0.03-75).
Data analysis
Standard descriptive statistics were used. Univariable and Cox proportional multivariable analyses were used to identify predictors of early and late mortality. The Wilcoxon Rank Sum Test was employed to compare SF-36 scores. Nonparametric Kaplan-Meier survival analysis was performed. A value of P < 0.05 was statistically signiWcant.
Results
Mean age was 83.7 ± 3.4 years (range 80-96, median 83); 36 (62%) were males. All patients were symptomatic. Associated risk factors, co-morbidities and symptoms at presentation are presented in Table 1 . All had an echocardiogram; mean aortic valve area was 0.65 ± 0.2 cm 2 (median 0.60, range 0.3-1.1). Mean ejection fraction was 40±20%. A bioprosthetic valve was inserted in 55 (95%) patients. Concomitant coronary artery bypass grafting (CABG) was performed in 28 (48%) patients.
Morbidity and mortality
A complication occurred in 47 (81%) patients (Table 2) . Infectious sources were mainly pulmonary, genitourinary and skin. Median length of incubation for respiratory failure was 114.0 hours (range 45-615 hours).
The operative mortality rate was 8.6% overall, 6.7% for isolated AVR and 10.7% for AVR+CABG; causes of death were mainly cardiovascular and sepsis. Univariate predictors of operative mortality were mitral regurgitation, ventricular Actuarial survival at 1, 3 and 5 years was, respectively, 86, 76 and 73%. Survival for isolated AVR patients was better than that of patients with AVR+CABG (P<0.05).
QOL
Of patients followed, 27 (61%) were NYHA class I, 16 (36%) class II and 2 (3%) class III. Postoperative SF-36 scores, when compared with <80 years, were better for BP, vitality, SF and MH (P<0.05); when compared with the general population ≥75 years they were better for BP, GH, vitality, SF and MH (P<0.05).
Comment
AS progresses rapidly in patients ≥80 years; the medically treated 4-year survival is 24%. All patients with AS are at increased risk of sudden death, but only 5% of asymptomatic patients die suddenly. The onset of symptoms is ominous and indicates a life expectancy of <5 years. Life expectancy in half of the patients with angina is less than 5 years; with syncope, >3 years and, with congestive heart failure <2 years. Presently, cardiac operations in selected elderly individuals showed improved survival and QOL.
Morbidity and mortality
Morbidity in this age group can be elevated (20-92%) [4, 5] . In our experience, some type of complication occurred in 81% of patients. Because of increased age, frailer constitution and chronic diseases, this Wnding was not unexpected. Low cardiac output syndrome, atrial Wbrillation, infection and renal failure were common causes of morbidity [6] .
Operative mortality was 8.6% overall, 6.7% for isolated AVR and 10.7% for AVR+CABG; all comparable with the literature [3, 4, 7] . Only postoperative ventricular dysrhythmias predicted operative mortality on multivariable analysis, suggesting a poor tolerance of the elderly to this complication [3] ; efforts should be made to maintain sinus rhythm after AVR.
Overall survival at 1, 3 and 5 years of 86, 76 and 73%, respectively, were similar to the largest series [2, 3] . Heavily symptomatic patients with renal insufWciency or with combined procedures had poor long-term survival.
QOL
With increased postoperative morbidity, patients ≥80 years spend a greater proportion of life expectancy in recovery. This time may be difWcult or debilitating, impacting their QOL. Various instruments have been used to characterize their QOL improvements [2, 8] . All of these studies have shown an improvement in patients' status from the preoperative to postoperative period. The limitation of these reports lies upon the absence of a standardised QOL tool, thus making their generalisability difWcult.
In contrast, the MOS SF-36 is a standardised instrument [9] , which has been used to assess QOL on patients ≥80 years post AVR [7] . The limitation has been the lack of preoperative SF-36 data. In our study, preoperative SF-36 scores indicated that ≥80 years patients had comparable QOL with that of their younger counterparts, even enjoying better mental health (less anxiety, better behavioural-emotional control and positive affect). Postoperatively, despite increased morbidity, ≥80 years patients had good QOL outcomes with less bodily pain, better general health, vitality, social functioning and mental health.
Sensitive economic and ethical issues arise in connection with any treatment previously regarded as aggressive, costly and of uncertain beneWt. With regards to costs, it has been reported that patients ≥80 years did not require more hospital resources when compared with younger patients (65-75 years). As such, fear of increased costs should not be a deterrent to treatment in this population.
Study limitations
A selection bias towards healthier patients may have taken place with those answering the questionnaires being of better functional class. Preoperative and postoperative response rates to questionnaires were low and may have biased our QOL Wndings and conclusions; reasons given for refusal included lack of interest, questionnaire too lengthy, too nervous to concentrate and lack of time. Response rates may be improved by using a shortened questionnaire (SF-12, 12 questions instead of 36). The MOS-SF36 developer group observed that older patients tended to have lower response rates in general (65-75%).
Conclusions
Despite higher operative risk and greater morbidity, QOL indicators in patients ≥80 years were equivalent to or better than their counterparts. Effects of exercise training on bone mineral density in frail older women and men: a randomised controlled trial SIR-Prospective studies suggest that bone loss accelerates with advancing age [1, 2] , leading to markedly decreased bone mineral density (BMD). Because physical activity provides the mechanical stimulus for bone health [3] , low BMD in old age may be due, in part, to disuse atrophy [4] . Some randomised controlled trials (RCT) have found that exercise increases BMD in older adults [5] [6] [7] [8] [9] , but a limitation is that older physically frail individuals were not included. The aim of this study was to evaluate the effects of a multi-component exercise programme, compared with low intensity home exercise, on BMD in older frail individuals.
Methods
Participants were women and men (aged ≥78 years) recruited from the community. The screening procedures for this study have been described [10, 11] . All participants had mild-to-moderate physical frailty, deWned as meeting two out of the following three criteria: peak aerobic power of 11-18ml/kg/min, physical performance test score of 18-32, and difWculty or need for assistance with two instrumental or one basic activities of daily living. Exclusion criteria included medical conditions that contraindicated vigorous exercise, cancer diagnosis within the previous 5 years, use of bone-acting drugs within the previous year, and signiWcant sensory/cognitive impairment.
Eligible participants were randomly assigned to either an exercise training group (ET), or home exercise group (HOME). The study personnel who maintained the randomisation log were not involved in screening, testing or training procedures.
The ET program included successive phases of physical therapy (Phase 1), resistance (Phase 2), and endurance exercises (Phase 3), as previously described in detail [12, 13] . Phase 1 consisted of exercises designed to improve Xexibility, balance and coordination. Phase 2 added progressive resistance training and included leg press, knee extension, knee Xexion, seated row, upright row, bench press, biceps curl and triceps extension. Initially, 1-2 sets of 6-8 repetitions of each exercise were completed at 65-75% of one-repetition maximum (1-RM). This progressed to 3 sets of 8-12 repetitions done at 85-100% of 1-RM. Phase 3 added endurance exercises and included walking on a treadmill, cycling, and rowing. The initial goal was to exercise 15 minutes at 65-75% of peak heart rate and progress to 30 minutes. After 4-6 weeks, the goal was to perform four 5-minute intervals at 85-90% of peak heart rate. The HOME program consisted of a subset of the Phase 1 exercises of the ET program.
Participants completed 3-day food records at the beginning and end of the study. Participants were provided supplemental calcium and vitamin D to adjust intake to about 1200 mg/day and about 800 U/day, respectively.
BMD of the whole body, lumbar spine, and proximal femur was measured at 3-mo intervals using dual-energy X-ray absorptiometry (DXA) (DXA; Hologic Inc, Waltham, MA) on a Hologic QDR-1000/W instrument. CoefWcients of variation were 0.6 ± 0.2 to 1.1 ± 0.6%.
Baseline characteristics were compared using unpaired t-tests and χ 2 tests except where nonparametric alternatives were used. Longitudinal analyses were performed using mixed model repeated measures ANOVA (SAS: Cary, NC). The focus of the analyses was on the signiWcance of the Group × Time interaction. Statistical contrasts were used in testing hypotheses that changes between two time-points in one group was equal to changes in the other group. Results are reported as mean ± SD.
Results
We prescreened 657 individuals and invited 444 for screening evaluations. Of these, 165 did not meet selection criteria, 67 elected to enroll in a concurrent study of exercise combined with hormone replacement therapy (HRT) and 93 declined participation. One hundred and nineteen individuals were randomised: 69 to ET and 50 to HOME. Of these, 87 completed the study and 32 dropped out. Reasons for drop-out included: death (1 HOME), personal reasons (3 ET, 4 HOME), medical problems (17 ET, 4 HOME), and noncompliance (3 ET). Seven participants were excluded due to incomplete data (4 ET, 3 HOME). Of the
